Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
Margaret Hellard(Burnet Institute), Natasha K. Martin(University of California San Diego), Rachel Sacks‐Davis(Burnet Institute), Peter Vickerman(University of Bristol), Judy Gold(Burnet Institute), Mark Stoové(Monash University), Matthew Hickman(University of Bristol), Rebecca Jenkinson(Burnet Institute), Peter Higgs(Curtin University)
Cited by 57
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
MAIT cells are activated during human viral infections
|Nature Communications|2016|520